NCT03776032 2018-12-20A Novel Erythropoiesis Stimulating Protein (NESP; Darbopoetin Alfa) for the Treatment of Anemia in Lung Cancer Patients Receiving Multi-cycle Platinum-Containing ChemotherapyAmgenPhase 3 Completed320 enrolled
NCT01444456 2017-03-20Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced AnaemiaAmgenCompleted1,262 enrolled 14 charts
NCT00003600 2016-07-13Epoetin Alfa in Treating Anemia in Patients Who Are Receiving ChemotherapyAlliance for Clinical Trials in OncologyPhase 3 Completed344 enrolled
NCT00077311 2016-06-30Docetaxel and Cisplatin With or Without Dimesna in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung CancerAlliance for Clinical Trials in OncologyPhase 2 Completed160 enrolled
NCT00072059 2013-07-18Ro 50-3821 in Treating Anemia in Patients Receiving Antineoplastic Therapy for Stage IIIB or Stage IV Non-Small Cell Lung CancerNational Cancer Institute (NCI)Phase 2 Completed
NCT00270166 2011-05-18The Effect of Epoetin Alfa on the Anemia of Patients With Selected Cancers Receiving ChemotherapyJohnson & Johnson Pharmaceutical Research & Development, L.L.C.Phase 3 Completed201 enrolled
NCT00120679 2007-12-24Treatment for Patients With Non-Small Cell Lung Cancer Who Developed Anemia Due to ChemotherapyAmgenPhase 2 Completed